SNIPR BIOME

In Gothenburg next week for Nordic Life Science Days. Attending too? Reach out to @evdh.bsky.social for a quick chat. #NLSDays2025

Next week, on Thursday 18 September, Jonas Eegholm will present SNIPR BIOME’s poster in Heidelberg at the @embo.org | @embl.org Symposium – The human microbiome titled “Characterisation and functionalization of a type IV #CRISPR-Cas system for bacterial engineering.”

Our CEO, Christian Groendahl, will be presenting at the 83rd International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences in Copenhagen, in the session LSMO-01: Novel antimicrobials in the pipeline on Monday, 1 September 2025 from 13:00–14:00.

SNIPR BIOME Raises EUR 35 Million Series B Financing to Advance CRISPR-Medicines Targeting Antimicrobial Resistance SNIPR Biome today announced the close of a EUR 35 million Series B financing round addressing antimicrobial resistance and infectious disease....

Full press release: www.globenewswire.com/news-release...

We proudly announced the close of a €35 million Series B financing!

#AMR #CRISPR #SeriesB

New open position at SNIPR BIOME: Are you a skilled Laboratory Technician that can drive and maintain our laboratory and have an interest in supporting projects across our research organization? Apply here: www.linkedin.com/jobs/view/42... before June 26th

SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer SNIPR BIOME today announced that the first patient has been dosed in its Phase 1b study of SNIPR001 in patients with hematological cancer....

Full press release: www.globenewswire.com/news-release...

SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer— the first CRISPR-armed phage therapeutic designed to target E. coli in the gut.
@carb-x.bsky.social Read the full press release in the link below 👇

Looking forward to meeting at #BIO2025! Reach out if you'd like to connect with Christian Groendahl and me in Boston June 16-19. DM here or email partnering@sniprbiome.com. @sniprbiome.com

We are hiring for two key roles in our growing SNIPR BIOME team in Copenhagen. We are looking for:

- Bioinformatician / Data Scientist lnkd.in/dp_GAHRY

- Research Assistant in Phage Engineering lnkd.in/dXER77Hj

Join the SNIPR Biome - A CRISPR Company Team in Copenhagen🇩🇰!
We're hiring a Bioinformatician/Data Scientist passionate about bacterial genomics and microbiome science. Deadline is already in two weeks. www.linkedin.com/jobs/view/42...

This week, our Director of Bacterial Engineering Szabolcs Semsey will present a poster on the latest CRISPR-Cas systems at the Gordon Research Conferences on Bacterial Cell Biology and Development, held at Southern New Hampshire University.

Christian Groendahl and @evdh.bsky.social will be attending next week's #BioEquity in Bruges🇧🇪.

Reach out to learn more about our recent progress and updates of our pipeline.
#partnering #BioEquityEurope

Meet SNIPR BIOME next week: Jakob & @evdh.bsky.social at Venture @sprind-en.bsky.social Berlin (Apr 8), Alice discussing untreatable infections at EU Parliament, and Christian & Anders at @escmid.bsky.social Vienna (Apr 10-14). Don't miss our SNIPR001 poster (P2537) Apr 13, 12:00–13:30, Hall D!

Next week, Christian Groendahl and @evdh.bsky.social will be attending #BIOEuropeSpring in Milan. Looking forward to sharing updates on SNIPR Biome’s exciting CRISPR technology pipeline. If you'll be there, please reach out via partnering@sniprbiome.com. We look forward to connecting!

Pleased to participate yesterday in the #HERAInfoDay in Copenhagen. Our CEO and co-founder Christian Groendahl, presented on how critical funding from the European Health Emergency Preparedness and Response Authority (#HERA) and @eib.org has significantly advanced SNIPR001

Register — Microbiome Times Forum

Register here www.microbiomeforum.com/register

Our Director of Preclinical Testing, Aurelie Gram, will join the first Microbiome Times Partnering Forum in Brussels later this month to discuss the development of CRISPR-Cas therapeutic SNIPR001.
Registration link in the comments

SNIPR Biome Strengthens IP Portfolio with Patent Granted for a Novel CRISPR-Cas System Grant of a patent on February 26th 2025 by the European Patent Office protecting the newly-discovered and characterised CRISPR-CasS system....

Read the full release here: www.globenewswire.com/news-release...

SNIPR Biome strengthens IP portfolio with a patent granted for a novel #CRISPR-Cas system! Read more in the press release below.

We are looking for an early career Research Assistant @sniprbiome.com to develop new medicines within infectious and metabolic diseases. Application deadline is 10th February 2025 www.linkedin.com/jobs/view/41...